Fulcrum Therapeutics to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019
November 06 2019 - 8:01AM
Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage
biopharmaceutical company focused on improving the lives of
patients with genetically defined rare diseases, today announced
that it will host a live conference call and webcast at 8:00 a.m.
ET on Thursday, November 14, 2019 to report its third quarter 2019
financial results and provide a corporate update.
The live call may be accessed by dialing (800) 527-6973 for
domestic callers or (470) 495-9162 for international callers and
providing the conference ID number 1688051. An audio webcast of the
call will be available on the Company's website at
https://ir.fulcrumtx.com/events-and-presentations. Following the
live webcast, an archived replay will also be available.
About Fulcrum Therapeutics Fulcrum Therapeutics is
a clinical-stage biopharmaceutical company focused on improving the
lives of patients with genetically defined rare diseases in areas
of high unmet medical need. Fulcrum’s proprietary product engine
identifies drug targets which can modulate gene expression to treat
the known root cause of gene mis-expression. Please visit
www.fulcrumtx.com.
Investor Contact:Christina Tartaglia Stern
Investor Relations, Inc.
212.362.1200christina@sternir.com
Media Contact: Kaitlin GallagherBerry &
Company Public
Relationskgallagher@berrypr.com 212-253-8881
Fulcrum Therapeutics (NASDAQ:FULC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fulcrum Therapeutics (NASDAQ:FULC)
Historical Stock Chart
From Sep 2023 to Sep 2024